Danaher (DHR) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2358511028

Biotechnology, Diagnostics, Life Sciences

Danaher Corporation is a global leader in designing, manufacturing, and marketing a wide range of innovative products and services that cater to various industries, including healthcare, biotechnology, and industrial markets.

The company's Biotechnology segment is a pioneer in providing cutting-edge bioprocess technologies, consumables, and services that accelerate and integrate the development and manufacture of therapeutics. This includes cell line and cell culture media development services, chromatography resins, filtration technologies, and single-use hardware and consumables. Additionally, they offer lab-scale protein purification and analytical tools, reagents, membranes, and healthcare filtration solutions.

The Life Sciences segment is a powerhouse of innovative products and services, offering a broad portfolio of instruments and consumables, including mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies, and reagents. They also provide industrial filtration products, genomic medicines, and custom nucleic acid products, plasmid DNA, RNA, and proteins under well-known brands such as ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX.

The Diagnostics segment is a leading provider of diagnostic solutions, offering chemistry, immunoassay, microbiology, and automation systems, as well as molecular, acute care, and pathology diagnostics products. They also provide clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings.

With a rich history dating back to 1969, Danaher Corporation has undergone significant transformations, including a name change from Diversified Mortgage Investors, Inc. in 1984. Today, the company is headquartered in Washington, D.C. and continues to drive innovation and growth in the industries it serves. For more information, visit their website at https://www.danaher.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Danaher (DHR) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Danaher (DHR) - Stock Price & Dividends

DHR Stock Overview

Market Cap in USD 187,201m
Sector Healthcare
Industry Diagnostics & Research
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1979-01-05

DHR Stock Ratings

Growth 5y 56.9
Fundamental 28.8
Dividend 7.41
Rel. Performance vs Sector 0.64
Analysts 4.13/5
Fair Price Momentum 248.61 USD
Fair Price DCF 205.63 USD

DHR Dividends

Yield 12m 0.40%
Yield on Cost 5y 0.82%
Dividends CAGR 5y 10.40%
Payout Consistency 94.3%

DHR Growth Ratios

Growth 12m 21.72%
Growth Correlation 12m 59%
Growth Correlation 3m 43%
CAGR 5y 15.26%
CAGR/Mean DD 5y 1.24
Sharpe Ratio 12m 0.73
Alpha vs SP500 12m -1.67
Beta vs SP500 5y weekly 0.85
ValueRay RSI 16.37
Volatility GJR Garch 1y 20.84%
Price / SMA 50 0.32%
Price / SMA 200 8.52%
Current Volume 3366.8k
Average Volume 20d 3094.8k

External Links for DHR Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of DHR stocks?
As of June 18, 2024, the stock is trading at USD 254.13 with a total of 3,366,800 shares traded.
Over the past week, the price has changed by -3.98%, over one month by -4.39%, over three months by +1.17% and over the past year by +19.11%.
What are the forecast for DHR stock price target?
According to ValueRays Forecast Model, DHR Danaher will be worth about 274.6 in June 2025. The stock is currently trading at 254.13. This means that the stock has a potential upside of +8.04%.
Issuer Forecast Upside
Wallstreet Target Price 271.4 6.79
Analysts Target Price 246.8 -2.87
ValueRay Target Price 274.6 8.04

The Evolution and Current Standings of Danaher Corporation

History

Founded in 1969 by Steven Rales and Mitchell Rales, Danaher Corporation started off as a real estate investment trust. It was not long before the company pivoted towards manufacturing and the science and technology sector, embarking on a strategy of growth through acquisitions. This approach propelled Danaher from its modest beginnings into a global conglomerate.

Core Business

Danaher's core business today revolves around the design, manufacturing, and marketing of professional, medical, industrial, and commercial products and services. The enterprise is organized around three main segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Each segment plays a critical role in research, healthcare, and industrial processes, contributing to advancements across various fields.

Side Business

Besides its pillars, Danaher engages in several side businesses, broadening its influence across the tech and innovation world. These include ventures in dental products, water quality solutions, and product identification. Notably, the company's strategy involves investing in businesses that complement its core operations, thereby strengthening its overall market position.

Current Market Status

As of the latest market analysis, Danaher Corporation (NYSE: DHR) has proven itself a formidable player within its industry. With a steady rise in stock prices and a strong presence in its sectors, Danaher continues to grow. The company's dedication to innovation, strategic acquisitions, and diversification of its product lineup and services keeps it at the forefront of emerging technologies and market trends.